Patents by Inventor Iddo Gescheit

Iddo Gescheit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10940266
    Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: March 9, 2021
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Iddo Gescheit, Hans-Juergen Kuhr
  • Patent number: 10369281
    Abstract: Devices, systems and methods for adjusting fluid delivery based on past or historical fluid delivery data and/or personal parameters of a user are disclosed. Devices, and corresponding systems and methods, may comprise a dispensing unit configured to deliver a fluid from a reservoir into the body of a user and a processor having instructions operating thereon to retrieve data relating to one or more time windows from a memory, assess a correction delivery for the one or more time windows based on the data, determine a new CIR value for the one or more time windows if the correction delivery regularly follows a meal bolus and/or determine a new basal delivery profile for the one or more time windows if the correction delivery regularly precedes a meal bolus.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: August 6, 2019
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20180361063
    Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.
    Type: Application
    Filed: August 24, 2018
    Publication date: December 20, 2018
    Inventors: Iddo Gescheit, Hans-Juergen Kuhr
  • Patent number: 10080840
    Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: September 25, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Iddo Gescheit, Hans-Juergen Kuhr
  • Patent number: 9872959
    Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: January 23, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20160228641
    Abstract: A control unit for an electronically controlled pump unit controls the pump unit to infuse insulin into a diabetic's body in a substantially continuous way according to a preset infusion schedule as a function of time. The control unit includes an intervention unit that continuously evaluates a blood-glucose indicative input for detecting an actual or expected hypoglycaemia and executes, in response to an actual or expected hypoglycaemia, a temporary hypoglycaemia intervention. The intervention includes, for an intervention time interval, overriding the preset infusion schedule by temporarily suspending insulin infusion or temporarily reducing insulin infusion below the preset infusion schedule. The intervention unit adapts its way of operation with respect to executing the hypoglycaemia intervention in accordance with a control signal that is separate from the blood-glucose indicative input. The control unit automatically generates the control signal as a function of time and/or based on sensor input.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 11, 2016
    Inventors: Iddo Gescheit, Hans-Juergen Kuhr
  • Publication number: 20160106918
    Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 21, 2016
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Patent number: 9244077
    Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: January 26, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20150157788
    Abstract: A therapeutic system configured for the delivery of fluid. The therapeutic system in an exemplary embodiment comprises a fluid delivery device having a fluid reservoir, an outlet port with a lumen for outputting the fluid from the reservoir, a pump for pumping the fluid through the lumen and a controller for controlling the therapeutic system. The therapeutic system may also comprise an adaptor for an infusion set, the adaptor having a plug operable for attaching to the outlet port, and wherein the adaptor also has an adaptor septum operable for being pierced by the lumen when attached to the outlet port. The therapeutic system further comprises an infusion set recognition system, wherein the controller is further operable to query the infusion set recognition system for infusion set data, wherein the infusion set data comprises an infusion set type, wherein the controller is further operable to operate the pump to provide a basal dosage of the fluid if the infusion set type is not recognized.
    Type: Application
    Filed: February 18, 2015
    Publication date: June 11, 2015
    Inventors: Iddo Gescheit, Avraham Neta, Ofer Yodfat
  • Publication number: 20150151041
    Abstract: A transfer station for transferring a medical fluid between at least one supply container and at least one administration container of an infusion device is described. In an embodiment, the transfer station comprises at least one supply port configured for fluidic connection of the at least one supply container to the transfer station, and at least one exit port configured for fluidic connection of the at least one administration container to the transfer station. A transfer mechanism for automatically transferring a predetermined amount of medical fluid from the at least one supply container to the at least one administration container, and an electronic processing unit connected to an actuation means are provided with the transfer station. A processing unit controls the transfer mechanism and fluid transfer conditions according to a predetermined transfer demand entered by the actuation means.
    Type: Application
    Filed: February 11, 2015
    Publication date: June 4, 2015
    Inventors: Ofer Yodfat, Illai J Gescheit, Iddo Gescheit
  • Patent number: 8734383
    Abstract: Disclosed are systems, devices, and methods, including a system that includes a processor-based device implementing at least a residual insulin (RI) determination unit configured to determine a residual insulin in the patient's body at a particular time instance based on bolus doses previously delivered to the body of the patient, each bolus dose being associated with at least one dose value and a time representative of the time that dose value was delivered to the patient's body, and based on dose dependent RI time records that each includes at least a dose value and an associated duration value representative of dose-dependent duration of therapeutic effectiveness of the associated at least the dose value. The system also includes a pump to controllably dispense the insulin from a reservoir to the body of the patient based on the residual insulin determined by the RI determination unit.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: May 27, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ofer Yodfat, Iddo Gescheit, Gali Shapira
  • Patent number: 8480649
    Abstract: Embodiments of the present disclosure include methods, systems and devices for selecting a bolus configuration and may include one or more of providing a user interface for selection of one or more user interface elements, where each element corresponds to a bolus configuration of a drug, each element is spatially positioned within a multi-dimensional space corresponding to at least three dimensions and the element's position corresponding to each dimension.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: July 9, 2013
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Patent number: 8454510
    Abstract: A system and a method for determining an assessed carbohydrate to insulin ratio of a patient is described. The system and the method can comprise a memory component adapted for storing an initial set of values comprising at least one of a blood glucose level, a target blood glucose level, an insulin sensitivity, and, an estimated carbohydrate to insulin ratio. The system and the method can also comprise a bolus selection component adapted for selecting a test bolus corresponding to the determined initial set of values and a planned meal. In one implementation, the bolus selection component can receive bolus dose input from a user. In another implementation, the bolus selection component can estimate the bolus dose using a set of available inputs (e.g. the amount of carbohydrates in the planned meal). The system and the method can further comprise a user interface component adapted for receiving a confirmation that the test bolus has been administered to the patient.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: June 4, 2013
    Assignee: Medingo Ltd.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20120226259
    Abstract: Devices, systems and methods for adjusting fluid delivery based on past or historical fluid delivery data and/or personal parameters of a user are disclosed. Devices, and corresponding systems and methods, may comprise a dispensing unit configured to deliver a fluid from a reservoir into the body of a user and a processor having instructions operating thereon to retrieve data relating to one or more time windows from a memory, assess a correction delivery for the one or more time windows based on the data, determine a new CIR value for the one or more time windows if the correction delivery regularly follows a meal bolus and/or determine a new basal delivery profile for the one or more time windows if the correction delivery regularly precedes a meal bolus.
    Type: Application
    Filed: September 7, 2010
    Publication date: September 6, 2012
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20120220939
    Abstract: Disclosed are systems, devices, and methods, including a system that includes a processor-based device implementing at least a residual insulin (RI) determination unit configured to determine a residual insulin in the patient's body at a particular time instance based on bolus doses previously delivered to the body of the patient, each bolus dose being associated with at least one dose value and a time representative of the time that dose value was delivered to the patient's body, and based on dose dependent RI time records that each includes at least a dose value and an associated duration value representative of dose-dependent duration of therapeutic effectiveness of the associated at least the dose value. The system also includes a pump to controllably dispense the insulin from a reservoir to the body of the patient based on the residual insulin determined by the RI determination unit.
    Type: Application
    Filed: June 23, 2010
    Publication date: August 30, 2012
    Applicant: Medingo Ltd.
    Inventors: Ofer Yodfat, Iddo Gescheit, Gali Shapira
  • Publication number: 20120109047
    Abstract: Disclosed is a system to deliver insulin to a user's body. The system includes a dispensing unit to deliver the insulin to the body, and a control mechanism to control delivery of basal insulin according to a predetermined basal infusion pattern, the basal infusion pattern selected from a plurality of predetermined basal infusion patterns. In some embodiments, selection of the basal infusion pattern may be based on one or more personal characteristics of the user.
    Type: Application
    Filed: December 30, 2011
    Publication date: May 3, 2012
    Applicant: Medingo, Ltd.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Patent number: 8088098
    Abstract: Disclosed is a system to deliver insulin to a user's body. The system includes a dispensing unit to deliver the insulin to the body, and a control mechanism to control delivery of basal insulin according to a predetermined basal infusion pattern, the basal infusion pattern selected from a plurality of predetermined basal infusion patterns. In some embodiments, selection of the basal infusion pattern may be based on one or more personal characteristics of the user.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: January 3, 2012
    Assignee: Medingo, Ltd.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20110118699
    Abstract: Methods, systems and devices for sustained medical infusion of fluids are described. Some implementations describe portable infusion methods, systems and devices for selecting a pattern of fluid delivery. Some implementations describe skin securable insulin dispensing methods, systems and devices for selecting a delivery pattern according to the nutritional characteristics (e.g. glycemic index, GI, fat content, etc.) of caloric intake of the user.
    Type: Application
    Filed: April 28, 2009
    Publication date: May 19, 2011
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20110106050
    Abstract: Embodiments of the present disclosure include methods, systems and devices for selecting a bolus configuration and may include one or more of providing a user interface for selection of one or more user interface elements, where each element corresponds to a bolus configuration of a drug, each element is spatially positioned within a multi-dimensional space corresponding to at least three dimensions and the element's position corresponding to each dimension.
    Type: Application
    Filed: April 28, 2009
    Publication date: May 5, 2011
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20080319384
    Abstract: Disclosed is a system to deliver insulin to a user's body. The system includes a dispensing unit to deliver the insulin to the body, and a control mechanism to control delivery of basal insulin according to a predetermined basal infusion pattern, the basal infusion pattern selected from a plurality of predetermined basal infusion patterns. In some embodiments, selection of the basal infusion pattern may be based on one or more personal characteristics of the user.
    Type: Application
    Filed: June 25, 2008
    Publication date: December 25, 2008
    Applicant: Medingo, Ltd.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit